[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Microbot Medical Inc (MBOT)

Microbot Medical Inc (MBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 128,285
  • Shares Outstanding, K 67,165
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,140 K
  • EBIT $ -16 M
  • EBITDA $ -16 M
  • 60-Month Beta 1.04
  • Price/Sales 1,002.21
  • Price/Cash Flow N/A
  • Price/Book 1.73

Options Overview Details

View History
  • Implied Volatility 99.12% (-14.52%)
  • Historical Volatility 58.30%
  • IV Percentile 9%
  • IV Rank 8.64%
  • IV High 353.19% on 11/20/25
  • IV Low 75.08% on 01/20/26
  • Expected Move (DTE 11) 0.2210 (11.57%)
  • Put/Call Vol Ratio 0.03
  • Today's Volume 38
  • Volume Avg (30-Day) 350
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 23,346
  • Open Int (30-Day) 22,900
  • Expected Range 1.6890 to 2.1310

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.09
  • Number of Estimates 2
  • High Estimate $-0.08
  • Low Estimate $-0.09
  • Prior Year $-0.10
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7500 +9.14%
on 06/09/26
2.0388 -6.32%
on 07/01/26
-0.1000 (-4.98%)
since 06/02/26
3-Month
1.6600 +15.06%
on 05/19/26
2.6900 -29.00%
on 04/10/26
-0.4900 (-20.42%)
since 04/02/26
52-Week
1.6001 +19.37%
on 02/05/26
4.6700 -59.10%
on 09/08/25
-0.5900 (-23.60%)
since 07/02/25

Most Recent Stories

More News
Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader

HINGHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into a Letter of...

MBOT : 1.9100 (unch)
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System

HINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it has won...

MBOT : 1.9100 (unch)
Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System

Leading academic center with multi-hospital and multi-state health system deepens Company’s footprint in the Northeast U.S. The Company now has multiple accounts and hospitals that have adopted...

MBOT : 1.9100 (unch)
Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

HINGHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, has entered into an agreement...

MBOT : 1.9100 (unch)
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System

HINGHAM, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that one of the...

MBOT : 1.9100 (unch)
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System

HINGHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it has secured...

MBOT : 1.9100 (unch)
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System

Israel becomes the second jurisdiction and the first outside of the U.S. to grant marketing clearance for the LIBERTY System The AMAR regulatory approval will enable the Company to obtain a Free Sale...

MBOT : 1.9100 (unch)
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu

Conference call and live webcast to be held Monday, May 18 th at 3:00pm ET Wall Street firm publishes research report refuting claims made by recent unaffiliated third-party article; Research...

MBOT : 1.9100 (unch)
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026

Recent transition to the Full Market Release has already resulted in increased revenue for the current Q2, which has already exceeded Q1 revenue, as utilization and adoption of the LIBERTY System accelerates...

MBOT : 1.9100 (unch)
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites

Commercial adoption of the LIBERTY System by sites that participated in the clinical trial serves as a strong validation of the value it brings to everyday practice The Company will attend the Annual...

MBOT : 1.9100 (unch)

Business Summary

Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable...

See More

Key Turning Points

3rd Resistance Point 2.0800
2nd Resistance Point 2.0300
1st Resistance Point 1.9700
Last Price 1.9100
1st Support Level 1.8600
2nd Support Level 1.8100
3rd Support Level 1.7500

See More

52-Week High 4.6700
Fibonacci 61.8% 3.4973
Fibonacci 50% 3.1351
Fibonacci 38.2% 2.7728
Last Price 1.9100
52-Week Low 1.6001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.